Cargando…

Therapeutic Drug Monitoring of Quinidine in Pediatric Patients with KCNT1 Genetic Variants

Quinidine (QND) is an old antimalarial drug that was used in the early 20th century as an antiarrhythmic agent. Currently, QND is receiving attention for its use in epilepsy of infancy with migrating focal seizures (EIMFS) due to potassium sodium-activated channel subfamily T member 1 (KCNT1) geneti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferretti, Alessandro, Simeoli, Raffaele, Cairoli, Sara, Pietrafusa, Nicola, Trivisano, Marina, Dionisi Vici, Carlo, Specchio, Nicola, Goffredo, Bianca Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608568/ https://www.ncbi.nlm.nih.gov/pubmed/36297665 http://dx.doi.org/10.3390/pharmaceutics14102230

Ejemplares similares

Changing Times for CLN2 Disease: The Era of Enzyme Replacement Therapy
por: Specchio, Nicola, et al.
Publicado: (2020)

Impact of COVID-19 pandemic on pediatric patients with epilepsy – The caregiver perspective
por: Trivisano, Marina, et al.
Publicado: (2020)

Pharmacokinetic Evaluation of Eltrombopag in ITP Pediatric Patients
por: Dionisi, Marco, et al.
Publicado: (2021)

Therapeutic Drug Monitoring of Amphotericin-B in Plasma and Peritoneal Fluid of Pediatric Patients after Liver Transplantation: A Case Series
por: Tortora, Francesca, et al.
Publicado: (2022)

Use of Antibiotics in Preterm Newborns
por: Simeoli, Raffaele, et al.
Publicado: (2022)

Concurrent Quinidine and Phenobarbital in the Treatment of a Patient with 2 KCNT1 Mutations
por: Passey, Camerin C., et al.
Publicado: (2019)

Autism and Epilepsy in Patients With Tuberous Sclerosis Complex
por: Specchio, Nicola, et al.
Publicado: (2020)

Neurophysiological Findings in Neuronal Ceroid Lipofuscinoses
por: Trivisano, Marina, et al.
Publicado: (2022)

Case Report of Novel Genetic Variant in KCNT1 Channel and Pharmacological Treatment With Quinidine. Precision Medicine in Refractory Epilepsy
por: Kravetz, M. C., et al.
Publicado: (2021)

POLG1-Related Epilepsy: Review of Diagnostic and Therapeutic Findings
por: Specchio, Nicola, et al.
Publicado: (2020)

Quinidine Therapy for Lennox-Gastaut Syndrome With KCNT1 Mutation. A Case Report and Literature Review
por: Jia, Yu, et al.
Publicado: (2019)

Refractory Status Epilepticus in Genetic Epilepsy—Is Vagus Nerve Stimulation an Option?
por: Specchio, Nicola, et al.
Publicado: (2020)

Efficacy of Anti-seizure Medications, Quinidine, and Ketogenic Diet Therapy for KCNT1-Related Epilepsy and Genotype-Efficacy Correlation Analysis
por: Lin, Zehong, et al.
Publicado: (2022)

Therapeutic Drug Monitoring Is a Feasible Tool to Personalize Drug Administration in Neonates Using New Techniques: An Overview on the Pharmacokinetics and Pharmacodynamics in Neonatal Age
por: De Rose, Domenico Umberto, et al.
Publicado: (2020)

Two South Indian Children with KCNT1-Related Malignant Migrating Focal Seizures of Infancy – Clinical Characteristics and Outcome of Targeted Treatment with Quinidine
por: Patil, Abhijit Anil, et al.
Publicado: (2019)

Imbalance of Systemic Redox Biomarkers in Children with Epilepsy: Role of Ferroptosis
por: Petrillo, Sara, et al.
Publicado: (2021)

Is Cenobamate the Breakthrough We Have Been Wishing for?
por: Specchio, Nicola, et al.
Publicado: (2021)

Epileptic Encephalopathy
por: Specchio, Nicola, et al.
Publicado: (2012)

The Price of Quinidine
Publicado: (1922)

The Role of KRAS Mutations in Cortical Malformation and Epilepsy Surgery: A Novel Report of Nevus Sebaceous Syndrome and Review of the Literature
por: Pepi, Chiara, et al.
Publicado: (2021)

Cannabidiol Treatment for Refractory Epilepsies in Pediatrics
por: Raucci, Umberto, et al.
Publicado: (2020)

Antisense oligonucleotide therapy for KCNT1 encephalopathy
por: Burbano, Lisseth Estefania, et al.
Publicado: (2022)

Case Report: Causative De novo Variants of KCNT2 for Developmental and Epileptic Encephalopathy
por: Gong, Pan, et al.
Publicado: (2021)

Editorial: Therapeutic drug monitoring (TDM): a useful tool for pediatric pharmacology applied to routine clinical practice, Volume II
por: Simeoli, Raffaele
Publicado: (2023)

Modeling PCDH19-CE: From 2D Stem Cell Model to 3D Brain Organoids
por: Borghi, Rossella, et al.
Publicado: (2022)

Quinidine for Brugada syndrome: Panacea or poison?
por: Hai, Jo-Jo, et al.
Publicado: (2016)

Emerging role of the KCNT1 Slack channel in intellectual disability
por: Kim, Grace E., et al.
Publicado: (2014)

Functional consequences of a KCNT1 variant associated with status dystonicus and early‐onset infantile encephalopathy
por: Gertler, Tracy S., et al.
Publicado: (2019)

A UHPLC–MS/MS Method for Therapeutic Drug Monitoring of Aciclovir and Ganciclovir in Plasma and Dried Plasma Spots
por: Pigliasco, Federica, et al.
Publicado: (2021)

Characterizing PCDH19 in human induced pluripotent stem cells (iPSCs) and iPSC-derived developing neurons: emerging role of a protein involved in controlling polarity during neurogenesis
por: Compagnucci, Claudia, et al.
Publicado: (2015)

The case for quinidine: Management of electrical storm in refractory ventricular fibrillation
por: Pinnelas, Rebecca, et al.
Publicado: (2020)

The Therapeutic Value of Quinidine Sulphate in Auricular Fibrillation
por: Ritchie, W. T.
Publicado: (1922)

Deuterated dextromethorphan/quinidine for agitation in Alzheimer's disease
por: Khoury, Rita
Publicado: (2021)

Incidence of Aicardi-Goutières syndrome and KCNT1-related epilepsy in Denmark
por: Møller, Rikke S., et al.
Publicado: (2022)

Action of quinidine on ionic currents of molluscan pacemaker neurons
Publicado: (1984)

Evidence for using dextromethorphan-quinidine for the treatment of agitation in dementia
por: Tampi, Rajesh R, et al.
Publicado: (2020)

Clinical and molecular characterization of KCNT1-related severe early-onset epilepsy
por: McTague, Amy, et al.
Publicado: (2018)

Epilepsy with migrating focal seizures: KCNT1 mutation hotspots and phenotype variability
por: Barcia, Giulia, et al.
Publicado: (2019)

Fatal Status Epilepticus in Dravet Syndrome
por: De Liso, Paola, et al.
Publicado: (2020)

Reply to Dravet, C. Different Outcomes of Acute Encephalopathy after Status Epilepticus in Patients with Dravet Syndrome. How to Avoid Them? Comment on “De Liso et al. Fatal Status Epilepticus in Dravet Syndrome. Brain Sci. 2020, 10, 889”
por: De Liso, Paola, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8vc3mgo7mgn6ihjqp1rt672pt8